Corporate Events

Genky DrugStores Co., Ltd. reported sales results for the month of September 2026. For the month, the company reported all store net sales change of 106.9% against 114.0% in 2025. Existing stores net sales change was 99.5% against 107.6% in 2025.

Genky DrugStores Co., Ltd., Board Meeting, Sep 10, 2026. Agenda: To consider and approve the Concerning Grant of Stock Options Share Acquisition Rights.

Genky DrugStores Co., Ltd. reported sales results for the month of August 2026. For the month, the company reported all store net sales change of 106.5% against 106.8% in 2025. Existing stores net sales change was 99.3% against 101.1% in 2025.

Genky DrugStores Co., Ltd., Board Meeting, Aug 17, 2026. Agenda: To submit for approval to the 9th Annual General Meeting of Shareholders to be held on September 10, 2026 a proposal to issue stock acquisition rights as stock options on particularly advantageous terms to the Company's Internal Directors and employees, and Directors and employees of the Company's subsidiaries.

Genky DrugStores Co., Ltd., Annual General Meeting, Sep 10, 2026.

Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the first half and full fiscal year ending June 20, 2027. For the first half, the company expects net sales of JPY 119,000 million, operating income of JPY 5,840 million, net income attributable to owners of parent of JPY 4,100 million and net income per share of JPY 134.40. For the year, the company expects net sales of JPY 244,000 million, operating income of JPY 12,000 million, net income attributable to owners of parent of JPY 8,200 million and net income per share of JPY 268.79.

Genky DrugStores Co., Ltd. proposed year-end dividend of JPY 6.50 per share for the fiscal year ended June 20, 2026 against JPY 6.50 per share a year ago. Scheduled date of commencing dividend payments is September 11, 2026. Scheduled date of convention of ordinary general meeting of shareholders: September 10, 2026. For the second quarter of fiscal year ending June 20, 2027, the company expected dividend of JPY 6.50 per share compared to JPY 6.50 per share a year ago. For the year ending June 20, 2027, the company expected dividend of JPY 6.50 per share compared to JPY 6.50 per share a year ago.

Genky DrugStores Co., Ltd. reported sales results for the month, second half and full year ending June 20, 2026. For the month, the company reported all store net sales change of 111.1% against 110.1% in 2025. Existing stores net sales change was 104.0% against 102.9% in 2025. For the second half, the company reported all store net sales change of 109.1%. Existing stores net sales change was 101.7%. For the full year, the company reported all store net sales change of 109.8%. Existing stores net sales change was 102.9%.

Genky DrugStores Co., Ltd. announced that they will report fiscal year 2026 results at 9:00 AM, Tokyo Standard Time on Jul 28, 2026

Genky DrugStores Co., Ltd. reported sales results for the month of April 2026. For the month, the company reported all store net sales change of 109.4% against 113.0% in 2025. Existing stores net sales change was 101.7% against 106.5% in 2025.

Genky DrugStores Co., Ltd. reported earnings results for the nine months ended March 20, 2026. For the nine months, the company reported sales was JPY 161,710 million compared to JPY 147,383 million a year ago. Net income was JPY 5,621 million compared to JPY 4,873 million a year ago. Basic earnings per share from continuing operations was JPY 184.61 compared to JPY 160.34 a year ago. Diluted earnings per share from continuing operations was JPY 183.97 compared to JPY 160.04 a year ago.

Genky DrugStores Co., Ltd. announced that they will report Q3, 2026 results on Apr 28, 2026

Genky DrugStores Co., Ltd. reported sales results for the month of March 2026. For the month, the company reported all store net sales change of 110.7% against 106.5% in 2025. Existing stores net sales change was 103.1% against 100.6% in 2025.

Genky DrugStores Co., Ltd. reported sales results for the month of January 2026. For the month, the company reported all store net sales change of 105.7% against 111.1% in 2025. Existing stores net sales change was 98.6% against 106.1% in 2025.

Genky DrugStores Co., Ltd. announced a dividend of JPY 6.50 per share for the six months ended December 20, 2025 against JPY 6.50 per share a year ago. Scheduled date of commencing dividend payments: February 27, 2026.

Genky DrugStores Co., Ltd. reported earnings results for the half year ended December 20, 2025. For the half year, the company reported sales was JPY 109,261 million compared to JPY 98,758 million a year ago. Net income was JPY 4,020 million compared to JPY 3,268 million a year ago. Basic earnings per share from continuing operations was JPY 132.12 compared to JPY 107.55 a year ago. Diluted earnings per share from continuing operations was JPY 131.63 compared to JPY 107.33 a year ago.

Genky DrugStores Co., Ltd., ¥ 6.50, Cash Dividend, Jun-18-2026

Genky DrugStores Co., Ltd. expected to report Q3 2026 results on April 20, 2026. This event was calculated by S&P Global (Created on January 27, 2026).

Genky DrugStores Co., Ltd. revised consolidated earnings guidance for the Second Quarter (Interim Period) ending December 20, 2025 and year ending June 20, 2026. for the Second Quarter (Interim Period), the company expects Net sales of JPY 109,261 million, Operating Income of JPY 5,717 million, Interim Net Income attributable to owners of parent of JPY 4,020 million and Interim Net income per share of JPY 132.12 against Net sales of JPY 109,210 million, Operating Income of JPY 5,270 million, Interim Net Income attributable to owners of parent of JPY 3,700 million and Interim Net income per share of JPY 121.72 expected previously. Reasons for the revision: Comparison of First-Half Results with the Plan: Net sales were generally in line with the plan. However, the number of new store openings fell short of the plan by 1 store due to timing differences. The gross profit margin exceeded the plan by +0.3 pts in the first quarter, and this upside was allocated from the second quarter onward to price competitiveness measures within a range that does not affect the full-year gross profit margin. As a result, the gross profit margin in the second quarter was -0.1 pts below the plan, while the first-half cumulative margin was +0.1 pts above the plan at 20.39%. In addition, weaker performance in non-food products in the second quarter, re- flecting heightened consumer price sensitivity, also contributed to the slight shortfall in the gross profit margin. Disposal losses for daily and fresh foods continued to be appropriately controlled, as in the first quarter. Selling, general and administrative expenses came in significantly below the initial plan by JPY 320 million, mainly due to personnel expenses, which were JPY 340 million below plan. As this fiscal year is the first year of full-scale rollout of self-checkout systems across all stores, the initial personnel cost plan was set conservatively in anticipation of potential operational issues. However, thorough labor hour control by the store operations division enabled efficient store management, contributing to the reduction versus plan. As a result, while net sales were in line with the plan, gross profit exceeded the plan by JPY 120 mil- lion and SG&A expenses were below the plan by JPY 320 million, and operating profit, ordi- nary profit, and profit attributable to owners of parent are all expected to exceed the forecasts. For the year, the company expects Net sales of JPY 221,200 million, Operating Income of JPY 11,050 million, Net Income attributable to owners of parent of JPY 7,850 million and Net income per share of JPY 257.55 against Net sales of JPY 221,840 million, Operating Income of JPY 10,500 million, Net Income attributable to owners of parent of JPY 7,500 million and Net income per share of JPY 246.74 expected previously. Revision of the Forecast for the Second Half: The number of new store openings in the second half has been revised downward from 45 stores to 41 stores. Including adjustments to opening schedules, second-half net sales are expected to be lower than the initial plan by JPY 690 million. Although lease agreements for all planned sites had been completed, construction costs have risen and construction schedules have become increas- ingly tight. In particular, construction costs directly affect store profitability, and as the company continued negotiations without compromise to ensure they do not exceed its internal standards, some store openings have been postponed to the next fiscal year. The number of store closures remains unchanged from the initial plan at 3 stores for the full year, and the net increase in the number of stores at fiscal year-end is expected to be +58 stores. Com- pared with the net increase of +47 stores in the previous fiscal year, this represents an increase of more than 20% in the pace of new store openings, even while maintaining a focus on dominant areas. the company strongly feel that the organizational strengthening of the Store Development Division, which is key to its store expansion strategy, over the past several years has produced tangible results. Looking ahead, the Market Research Division, Store Development Division, and Construction Division will continue to work as an integrated team, and the company intend to accelerate toward achiev- ing an annual pace of 100 new store openings as early as possible. The gross profit margin plan for the second half has been slightly revised downward by 0.03 pts versus the initial plan; however, due to the reduction in sales, gross profit is expected to be lower than the initial plan by JPY 180 million. SG&A expenses have been revised downward by JPY 280 million versus the initial plan, reflecting variances in personnel expenses and utility costs observed in the first half. As a result, operating profit for the second half is expected to exceed the initial plan by JPY 100 million, and by JPY 500 million on a full-year basis. In addition, rising interest rates are pushing up non-operating expenses, and therefore the year-on-year growth in ordinary profit is expected to be slightly weaker than that of operating profit. On the other hand, the company is also working to improve non-operating income, including through leasing out large stores after closure.

Genky DrugStores Co., Ltd., Q2 2026 Earnings Call, Jan 30, 2026

Genky DrugStores Co., Ltd. reported sales results for the month of November 2025. For the month, the company reported all store net sales change of 109.1% against 104.5% in 2024. Existing stores net sales change was 102.2% against 99.7% in 2024.

Genky DrugStores Co., Ltd. announced that they will report Q2, 2026 results on Jan 27, 2026

Genky DrugStores Co., Ltd. reported sales results for the month of October 2025. For the month, the company reported all store net sales change of 107.9% against 110.4% in 2024. Existing stores net sales change was 101.8% against 105.8% in 2024.